Insider Transactions in Q3 2024 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-2.95%
|
$1,840,000
$46.0 P/Share
|
|
Sep 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.55%
|
$135,000
$45.51 P/Share
|
|
Sep 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+1.62%
|
$0
$0.46 P/Share
|
|
Aug 20
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.66%
|
$150,000
$50.0 P/Share
|
|
Aug 19
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
20,000
-2.84%
|
$1,000,000
$50.3 P/Share
|
|
Aug 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-2.73%
|
$1,920,000
$48.95 P/Share
|
|
Aug 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.36%
|
$240,000
$48.25 P/Share
|
|
Aug 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.64%
|
$0
$0.46 P/Share
|
|
Jul 22
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.65%
|
$165,000
$55.23 P/Share
|
|
Jul 16
2024
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,480
-1.11%
|
$191,400
$55.16 P/Share
|
|
Jul 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-0.77%
|
$3,360,000
$56.57 P/Share
|
|
Jul 15
2024
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,520
-1.69%
|
$908,600
$55.09 P/Share
|
|
Jul 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.37%
|
$270,000
$54.02 P/Share
|
|
Jul 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.64%
|
$0
$0.46 P/Share
|
|
Jul 01
2024
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,063
-0.13%
|
$103,150
$50.19 P/Share
|
|
Jul 01
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
20,000
-2.42%
|
$1,000,000
$50.15 P/Share
|
|
Jul 01
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,067
-0.29%
|
$103,350
$50.19 P/Share
|
|
Jul 01
2024
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,222
-0.23%
|
$211,100
$50.19 P/Share
|
|
Jul 01
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.64%
|
$150,000
$50.08 P/Share
|
|
Jul 01
2024
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,120
-0.16%
|
$106,000
$50.19 P/Share
|